Literature DB >> 28965744

Adding radiotherapy to chemotherapy in advanced NSCLC.

Vicki Brower.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28965744     DOI： 10.1016/S1470-2045(17)30771-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Montelukast ameliorated pemetrexed-induced cytotoxicity in hepatocytes by mitigating endoplasmic reticulum (ER) stress and nucleotide oligomerization domain-like receptor protein 3 (NLRP3) activation.

Authors:  Zhengdong Fei; Lu Zhang; Lei Wang; Hui Jiang; Aiqin Peng
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

2.  Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.

Authors:  Mengyao Sun; Yang Bai; Song Zhao; Xiyu Liu; Yongsheng Gao; Lei Wang; Bin Liu; Dashi Ma; Chunye Ma
Journal:  Oncotarget       Date:  2018-01-04

3.  CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.

Authors:  Hang Li; Jun Che; Mian Jiang; Ming Cui; Guoxing Feng; Jiali Dong; Shuqin Zhang; Lu Lu; Weili Liu; Saijun Fan
Journal:  Cell Commun Signal       Date:  2020-09-17       Impact factor: 5.712
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.